leadf
logo-loader
viewStabilitech BioPharma

Stabilitech Biopharma to take its 'revolutionary' COVID-19 vaccine capsule into the clinic

Stabilitech BioPharma's chairman Wayne Channon tells Proactive London's Andrew Scott they can reformulate nearly any vaccine so that it becomes thermally stable at any temperature.

Normally vaccines come out of a fridge and are injected into someone's arm but Stabilitech have come up with a vaccine that delivers double immunity via a capsule that can be swallowed.

They're looking to start clinical trials on their COVID-19 vaccine next month in June.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Alpha Growth's BlackOak Alpha Growth Fund generates positive returns despite...

Alpha Growth PLC (LON:ALGW) (OTCQB: ALPGF) CEO Gobind Sahney tells Proactive the financial services specialist's BlackOak Alpha Growth Fund produced a 2020 calendar year return of 10.63% and a 13.71% total return since inception in September 2019. Sahney says given the challenges of 2020, its...

1 day, 14 hours ago

2 min read